Cargando…
Targeting KRAS(G12C)-Mutated Advanced Colorectal Cancer: Research and Clinical Developments
Identifying mutations in the KRAS gene has become increasingly important in the treatment of colorectal cancer with many prognostic and therapeutic implications. However, efforts to develop drugs that target KRAS mutations have not been successful until more recently with the introduction of the KRA...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273901/ https://www.ncbi.nlm.nih.gov/pubmed/35837349 http://dx.doi.org/10.2147/OTT.S340392 |